0001209191-22-046521.txt : 20220817
0001209191-22-046521.hdr.sgml : 20220817
20220817214408
ACCESSION NUMBER: 0001209191-22-046521
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220816
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YEAMAN KEVIN J
CENTRAL INDEX KEY: 0001200469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 221176200
MAIL ADDRESS:
STREET 1: C/O DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-16
0
0001308547
Dolby Laboratories, Inc.
DLB
0001200469
YEAMAN KEVIN J
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
1
1
0
0
President and CEO
Class A Common Stock
2022-08-16
4
M
0
16688
42.98
A
38429
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
2022-08-16
4
S
0
16688
80.00
D
21741
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Class A Common Stock
107579
D
Employee Stock Option (right to buy)
42.98
2022-08-16
4
M
0
16688
0.00
D
2024-12-15
Class A Common Stock
16688
171816
I
By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
Shares held following the reported transactions include 107,579 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
This option was granted for a total of 291,598 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2014, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
/s/ Daniel Rodriguez, Attorney-in-Fact for Kevin Yeaman
2022-08-17